I want to talk to you about subclinical myocarditis.

There's new data that comes out from the European Society of Cardiology.

It's from Switzerland, and in honor of that, I'm drinking coffee from my Swiss mug.

Subclinical myocarditis and what it means for vaccination.

Let me walk you through the available data.

Now, we all know that mRNA vaccines are associated with myocarditis.

It's rare, but it is an important safety signal.

It's more likely to affect men than women.

I'm talking about clinical myocarditis after MRI vaccination, and it's more likely to affect

people in a certain age range, and that age range is about 16 to 24.

That's the peak demographic.

And it's still important from 24 to 40. It's still is about 16 to 24. That's the peak demographic. And it's still important

from 24 to 40. It's still important from 12 to 16. It's still probably important in 10 and 11, but it is

most important 16, 17, 18, 19, 20. That's the core group with the absolute highest risk. What you see

on your screen now is an analysis by Ali Krug,

Josh Stevenson, and Tracy Beth Hogg that appears in a European journal that shows you a

rate of myocarditis after vaccination stratified by age and gender. Now, many people try to

purport that COVID-19 is worse than vaccination and that it's always worse than vaccination. But

often what they do is they provide statistics for the aggregate population. They don't break it

down for men in that certain age group. That's a mistake because you can figure out pretty clearly

who are the men in that age group and you can provide different recommendations to those men.

Pfizer has a post-marketing commitment, according to this US FDA, to provide these data, the data

...